Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations
Communiqués de presse de la société ASTRAZENECA PLC
06:02aDAIICHI SANKYO : Announces Clinical Trial Collaboration with AstraZeneca to Eval..
AQ
08/06Japan, AstraZeneca to agree on 100 mil. COVID-19 vaccine dose supply
AQ
07/31SANOFI : AstraZeneca - Nirsevimab reduced respiratory syncytial virus infections..
AQ
07/30ASTRAZENECA : 2Q Earnings Snapshot
AQ
07/30ASTRAZENECA : Nirsevimab reduced respiratory syncytial virus infections and hosp..
PU
07/30ASTRAZENECA : Tagrisso granted Breakthrough Therapy Designation in the US for th..
PU
07/28ASTRAZENECA : Imfinzi recommended for approval in the EU by CHMP for extensive-s..
AQ
07/28DAIICHI SANKYO : and AstraZeneca Enter New Global Development and Commercializat..
AQ
07/28ASTRAZENECA : Calquence recommended for approval in the EU by CHMP for chronic l..
AQ
07/28ASTRAZENECA : Centus Biotherapeutics Announces Positive CHMP Opinion for FKB238,..
AQ
07/28ASTRAZENECA : Farxiga met all primary and secondary endpoints in groundbreaking ..
PU
07/27ASTRAZENECA : Imfinzi recommended for approval in the EU by CHMP for extensive-s..
AQ
07/27ASTRAZENECA : Calquence recommended for approval in the EU by CHMP for chronic l..
PU
07/27ASTRAZENECA : and Daiichi Sankyo enter collaboration to develop and commercialis..
PU
07/27ASTRAZENECA : Imfinzi recommended for approval in the EU by CHMP for extensive-s..
PU
07/24ASTRAZENECA : Breztri Aerosphere approved in the US for the maintenance treatmen..
PU
07/21ASTRAZENECA PLC : - COVID-19 vaccine AZD1222 showed robust immune responses in a..
AQ
07/20ASTRAZENECA : COVID-19 vaccine AZD1222 showed robust immune responses in all par..
AQ
07/20ASTRAZENECA : COVID-19 vaccine AZD1222 showed robust immune responses in all par..
PU
07/20ASTRAZENECA : Brilinta significantly reduced the rate of the composite of stroke..
AQ
07/16ASTRAZENECA : FARXIGA Granted Fast Track Designation in the US for Heart Failure..
BU
07/16ASTRAZENECA : BRILINTA Significantly Reduced the Rate of the Composite of Stroke..
BU
07/16ASTRAZENECA : Brilinta significantly reduced the rate of the composite of stroke..
PU
07/15ASTRAZENECA : Bob Harper and AstraZeneca Bring Virtual Series to Heart Attack Su..
BU
07/09ASTRAZENECA : Brilinta granted FDA Priority Review for the reduction of subseque..
PU
07/08ASTRAZENECA : Lynparza approved in the EU for BRCA-mutated metastatic pancreatic..
PU
06/30ASTRAZENECA : Selumetinib granted orphan drug designation in Japan for neurofibr..
PU
06/29ASTRAZENECA : Calquence showed long-term efficacy and tolerability for patients ..
AQ
06/24ASTRAZENECA : Breztri Aerosphere significantly reduced rate of moderate or sever..
PU
06/24ASTRAZENECA : PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacer..
BU
06/15ASTRAZENECA : Calquence showed long-term efficacy and tolerability for patients ..
AQ
06/15ASTRAZENECA : to supply Europe with up to 400 million doses of Oxford University..
AQ
06/12ASTRAZENECA : to showcase leadership in treating type-2 diabetes and cardiorenal..
AQ
06/12ASTRAZENECA : Calquence showed long-term efficacy and tolerability for patients ..
PU
06/11ASTRAZENECA : to Showcase Leadership in Treating Type 2 Diabetes and Cardiorenal..
BU
06/08FIBROGEN : AstraZeneca presents new data across continuum of care from its broad..
AQ
06/08Chugai Files for Expanded Use of FoundationOne CDx Cancer Genomic Profile as ..
AQ
06/08ASTRAZENECA : Calquence showed promising clinical improvement in majority of 19 ..
AQ
06/05ASTRAZENECA : Calquence showed promising clinical improvement in majority of 19 ..
PU
06/05ASTRAZENECA : takes next steps towards broad and equitable access to Oxford Univ..
AQ
06/04ASTRAZENECA : takes next steps towards broad and equitable access to Oxford Univ..
PU
06/04ASTRAZENECA : to discover and develop novel therapies targeting RNA-modifying pr..
AQ
06/02ASTRAZENECA : Lynparza recommended for approval in EU by CHMP for BRCA-mutated m..
AQ
06/01ASTRAZENECA : Enhertu and breast cancer
PU
06/01ASTRAZENECA : Lynparza
PU
06/01ASTRAZENECA : Calquence and haematology
PU
06/01ASTRAZENECA : Opening session
PU
06/01ASTRAZENECA : Tagrisso and immuno-oncology
PU
06/01DAIICHI SANKYO : AstraZeneca - Enhertu significantly improved tumour response ra..
AQ
06/01DAIICHI SANKYO : AstraZeneca and Daiichi Sankyo Company, Limited - Enhertu achie..
AQ
06/01DAIICHI SANKYO : AstraZeneca - Enhertu demonstrated meaningful clinical activity..
AQ
06/01ASTRAZENECA : Imfinzi plus tremelimumab demonstrated promising clinical activity..
AQ
06/01ASTRAZENECA : Imfinzi showed a sustained overall survival benefit in 1st-line ex..
AQ
06/01MERCK : Lynparza recommended for approval in EU by CHMP for BRCA-mutated metasta..
AQ
06/01ASTRAZENECA : BRILINTA Approved in the US to Reduce the Risk of a First Heart At..
BU
05/29ASTRAZENECA : Enhertu achieved a tumour response rate of 45.3% in patients with ..
PU
05/29ASTRAZENECA : Enhertu demonstrated meaningful clinical activity in patients with..
PU
05/29ASTRAZENECA : IMFINZI plus tremelimumab Demonstrated Promising Clinical Activity..
BU
05/29ASTRAZENECA : IMFINZI® (durvalumab) Showed a Sustained Overall Survival Benefit ..
BU
05/29ASTRAZENECA : ENHERTU (fam-trastuzumab deruxtecan-nxki) Demonstrated Meaningful ..
BU
05/29ASTRAZENECA : Enhertu significantly improved tumour response rate and overall su..
PU
05/29ASTRAZENECA : Imfinzi showed a sustained overall survival benefit in 1st-line ex..
PU
05/29ASTRAZENECA : ENHERTU (fam-trastuzumab deruxtecan-nxki) Achieved a Tumor Respons..
BU
05/29ASTRAZENECA : ENHERTU (fam-trastuzumab deruxtecan-nxki) Significantly Improved T..
BU
05/29ASTRAZENECA : collaborates with ArcherDX to use personalised cancer assays to de..
AQ
05/28ASTRAZENECA : TAGRISSO Demonstrated Unprecedented Patient Benefit in the Adjuvan..
BU
05/26ASTRAZENECA : collaborates with ArcherDX to use personalised cancer assays to de..
PU
05/22ASTRAZENECA : Enhertu granted Orphan Drug Designation in the US for gastric canc..
PU
05/22ASTRAZENECA : to start supplying potential coronavirus vaccine in Sept.
AQ
05/21BJ's, AstraZeneca rise; Hormel Foods, Medtronic fall
AQ
05/21ASTRAZENECA : advances response to global COVID-19 challenge as it receives firs..
AQ
05/21ASTRAZENECA : advances response to global COVID-19 challenge as it receives firs..
PU
05/20ASTRAZENECA : LYNPARZA® (Olaparib) Approved in the US for HRR Gene-Mutated Metas..
BU
05/18ASTRAZENECA : Bevespi Aerosphere approved in China for patients with COPD
AQ
05/18DAIICHI SANKYO : Enhertu granted Breakthrough Therapy Designation in the US for ..
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ASTRAZENECA PLC